Alodokter, the SoftBank Ventures-backed Indonesian digital health platform, has posted significant revenue growth even as its net losses widened for the year ended December 31, 2021, according to regulatory filings by its Singapore-registered parent company Ranelagh Pte Ltd.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
